Timken
Timken
Industrial ProductsKey Fundamentals
SmallcapAbrasives & BearingsIndustrial ProductsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 23.4%
Weaknesses
2- Stock is trading at 7.84 times its book value
- Promoter holding has decreased over last 3 years: -6.65%
Growth Rate
AI Analysis — Bull vs Bear
Timken India (market cap about ₹23,404 Cr) is almost debt-free and has grown sales and profit at 13% and 16% compounded over 10 years. Recent earnings have weakened: TTM profit is down 10% even though sales grew 12%, 3-year profit CAGR is 1%, and ROE slipped to 14% last year from a 5-year average of 18%. The stock trades at 54.7x earnings and about 8x book value, and it has returned 0% compounded over 3 years.
- The company is almost debt-free, so its balance sheet has little financial risk and room to fund capex in a cyclical industrial business.
- Long-term growth has been steady: 10-year sales CAGR of 13% and profit CAGR of 16%, with profit growing faster than sales, which suggests operating leverage over the cycle.
- The 5-year record is stronger still, with 19% sales CAGR and 23% profit CAGR, showing the business can grow quickly in a good demand environment.
- Revenue growth has picked up: TTM sales growth of 12% is well above the 3-year sales CAGR of 7%, a sign that demand may be recovering.
- ROE has stayed between 14% and 18% across the 1-, 3-, 5- and 10-year periods (10-year average of 16%) without relying on debt.
- Over the long run the stock has returned a 19% 10-year CAGR, compounding faster than the company's 16% 10-year profit growth.
- A dividend payout of 23.4% means about 76.6% of earnings is kept for reinvestment, alongside a steady dividend record.
- The P/E of 54.7 means an earnings yield of only about 1.8%. That leaves little room for error, especially while TTM profit is shrinking.
- The stock trades at about 7.81-8x book value with a latest ROE of 14%, a steep price for the return the company currently earns on equity.
- TTM profit fell 10% while sales rose 12%, which points to margin pressure from input costs, product mix or pricing.
- Over 3 years, profit grew at just a 1% CAGR against 7% sales growth, and the stock returned 0% compounded over the same period.
- ROE has fallen to 14% last year from a 5-year average of 18%, meaning the company is earning less on its capital.
- Promoter holding has dropped by 6.65 percentage points over the last 3 years, which reduces promoter ownership and could add supply of shares to the market.
- The dividend yield is 0.08%, so shareholders get almost no income return at the current price.
- The 1-year stock return of 3% trails the TTM sales growth of 12%, which shows the market is already reacting to the weaker profit trend.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- 39th AGM, ₹2.50 dividend declared Aug 18
Timken India held its 39th AGM on August 18, 2026, approving FY26 audited financials and declaring a final dividend of ₹2.50 per equity share.
TL;DR: Limited recent news flow for Timken India. The company held its routine AGM and declared a modest ₹2.50 per share final dividend for FY26, signaling steady but unremarkable capital return. With no significant headwinds or catalysts in the latest updates, the near-term outlook hinges on upcoming quarterly results and broader industrial demand trends.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 718 | 682 | 612 | 898 | 784 | 753 | 671 | 940 | 809 | 773 | 764 | 1,073 | 929 |
| Expenses | 582 | 546 | 510 | 699 | 643 | 620 | 565 | 730 | 666 | 635 | 669 | 838 | 757 |
| Operating Profit | 136 | 136 | 102 | 199 | 141 | 133 | 107 | 210 | 142 | 138 | 96 | 235 | 172 |
| OPM % | 19% | 20% | 17% | 22% | 18% | 18% | 16% | 22% | 18% | 18% | 13% | 22% | 19% |
| Other Income | 9 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 10 | 10 | 6 | 3 | 10 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 21 | 21 | 21 | 22 | 22 | 21 | 21 | 21 | 21 | 27 | 29 | 30 | 31 |
| PBT | 123 | 124 | 91 | 187 | 130 | 124 | 98 | 202 | 130 | 121 | 72 | 207 | 150 |
| Tax % | 27% | 25% | 26% | 24% | 26% | 27% | 24% | 7% | 20% | 26% | 31% | 25% | 23% |
| Net Profit | 90 | 93 | 68 | 141 | 96 | 90 | 74 | 187 | 104 | 89 | 50 | 155 | 115 |
| EPS in Rs | 11.98 | 12.37 | 8.98 | 18.8 | 12.8 | 11.96 | 9.88 | 24.84 | 13.86 | 11.89 | 6.63 | 20.58 | 15.31 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 926 | 1,042 | 1,056 | 1,233 | 1,664 | 1,618 | 1,411 | 2,203 | 2,807 | 2,910 | 3,148 | 3,419 | 3,540 |
| Expenses | 792 | 880 | 898 | 1,070 | 1,375 | 1,254 | 1,159 | 1,692 | 2,246 | 2,337 | 2,556 | 2,807 | 2,898 |
| Operating Profit | 134 | 162 | 158 | 163 | 289 | 363 | 252 | 511 | 560 | 572 | 592 | 612 | 642 |
| OPM % | 14% | 16% | 15% | 13% | 17% | 22% | 18% | 23% | 20% | 20% | 19% | 18% | 18% |
| Other Income | 6 | 3 | 10 | 21 | 16 | 23 | 20 | 14 | 53 | 41 | 50 | 28 | 28 |
| Interest | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 4 | 4 | 4 | 3 |
| Depreciation | 17 | 22 | 29 | 43 | 79 | 77 | 75 | 84 | 87 | 85 | 85 | 106 | 116 |
| PBT | 122 | 142 | 138 | 140 | 224 | 306 | 195 | 438 | 524 | 524 | 553 | 530 | 550 |
| Tax % | 34% | 35% | 30% | 34% | 34% | 20% | 27% | 25% | 25% | 25% | 19% | 25% | — |
| Net Profit | 81 | 92 | 97 | 92 | 149 | 246 | 143 | 327 | 391 | 392 | 447 | 398 | 409 |
| EPS in Rs | 11.87 | 13.5 | 14.29 | 13.53 | 19.76 | 32.72 | 19.04 | 43.49 | 51.95 | 52.13 | 59.48 | 52.96 | 54.41 |
| Div. Payout % | 25% | 7% | 7% | 7% | 5% | 153% | 8% | 3% | 3% | 5% | 61% | 5% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 68 | 68 | 68 | 68 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| Reserves | 370 | 462 | 550 | 634 | 1,266 | 1,501 | 1,268 | 1,582 | 1,962 | 2,342 | 2,770 | 2,898 |
| Borrowings | 3 | 4 | 8 | 16 | 23 | 24 | 35 | 32 | 31 | 25 | 17 | 15 |
| Other Liabilities | 144 | 168 | 251 | 261 | 411 | 377 | 510 | 505 | 489 | 545 | 564 | 763 |
| Total Liabilities | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,751 |
| Fixed Assets | 107 | 137 | 231 | 251 | 795 | 748 | 818 | 860 | 843 | 853 | 809 | 1,446 |
| CWIP | 27 | 21 | 58 | 54 | 64 | 157 | 97 | 50 | 53 | 104 | 592 | 101 |
| Investments | 17 | 38 | 91 | 55 | 176 | 13 | 0 | 99 | 236 | 161 | 117 | 180 |
| Other Assets | 435 | 506 | 498 | 619 | 741 | 1,060 | 973 | 1,185 | 1,424 | 1,870 | 1,908 | 2,025 |
| Total Assets | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,751 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 42 | 101 | 164 | 39 | 249 | 357 | 189 | 33 | 341 | 340 | 387 | 437 |
| Investing | -23 | -67 | -126 | -64 | -106 | -110 | -67 | -75 | -45 | -228 | -337 | -402 |
| Financing | -26 | 1 | -5 | -2 | -23 | -17 | -379 | -15 | -15 | -17 | -27 | -279 |
| Net Cash Flow | -7 | 36 | 34 | -27 | 119 | 230 | -257 | -57 | 281 | 94 | 23 | -243 |
| Free Cash Flow | 16 | 35 | 34 | -32 | 131 | 237 | 111 | -47 | 280 | 81 | 14 | 140 |
| CFO/OP | 65 | 94 | 129 | 47 | 112 | 121 | 93 | 29 | 88 | 82 | 89 | 94 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 68 | 66 | 66 | 66 | 66 | 96 | 89 | 75 | 82 | 81 | 85 |
| Inventory Days | 110 | 108 | 111 | 121 | 125 | 124 | 171 | 171 | 125 | 142 | 124 | 136 |
| Days Payable | 57 | 65 | 92 | 97 | 92 | 91 | 156 | 100 | 76 | 82 | 76 | 105 |
| Cash Conversion Cycle | 122 | 110 | 85 | 90 | 99 | 99 | 112 | 160 | 124 | 142 | 129 | 116 |
| Working Capital Days | 98 | 91 | 70 | 96 | 80 | 74 | 86 | 117 | 102 | 111 | 107 | 110 |
| ROCE % | 30% | 30% | 24% | 21% | 22% | 21% | 13% | 29% | 28% | 23% | 21% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Timken insights
63 extracted metrics + investor summaries across FY12–FY27.
Documents
Frequently Asked Questions about Timken
What does Timken India Ltd do?
Where is Timken India Ltd (TIMKEN) listed?
Which sector does Timken India Ltd belong to?
What is the market capitalisation of Timken India Ltd?
What is the PE ratio of Timken India Ltd?
What is the 52-week high and low of Timken India Ltd?
Does Timken India Ltd pay dividends?
What is the Return on Equity (ROE) of Timken India Ltd?
Company Information
Timken India Ltd is engaged in the manufacturing, distribution and sale of anti-friction bearings, components, accessories and mechanical power transmission products for the customer base across different sectors. It also provided maintenance contracts and refurbishment services and industrial services. It was incorporated in 1987 and is a part of the global Timken Group.[1][2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TIMKEN.md for Timken India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.